# Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer

> **NCT00052637** · PHASE3 · COMPLETED · sponsor: **Photocure**

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** hexaminolevulinate
- **PROCEDURE:** biopsy
- **PROCEDURE:** cystoscopy

## Key facts

- **NCT ID:** NCT00052637
- **Lead sponsor:** Photocure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2002-05
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00052637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00052637, "Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00052637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*